skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

APRESS: apical regulatory super system, serotonin, and dopamine interaction

Original Research

(3379) Views  (482) Full article downloads

Authors: Hinz M, Stein A, Uncini T

Published Date August 2011 Volume 2011:7(1) Pages 457 - 463
DOI: http://dx.doi.org/10.2147/NDT.S23676

Marty Hinz1, Alvin Stein2, Thomas Uncini3
1Clinical Research, NeuroResearch Clinics, Inc, Cape Coral, FL, USA; 2Stein Orthopedic Associates, Plantation, FL, USA; 3DBS Labs, Duluth, MN, USA

Background: The monoamines serotonin and dopamine are known to exist in two separate states: the endogenous state and the competitive inhibition state. The presence of the competitive inhibition state has been known to science for many years, but from a functional standpoint it has been noted in the literature as being "meaningless."
Methods: A large database of monoamine transporter response to amino acid precursor administration variations with clinical outcomes was accumulated. In the process, a new organic cation transporter (OCT) model has been published, and OCT functional status determination along with amino acid precursor manipulation methods have been invented and refined.
Results: Methodology was developed whereby manipulation of the OCT, in the competitive inhibition state, is carried out in a predictable manner. This, in turn, has disproved the long-held assertion that the monoamine competitive inhibition state is functionally meaningless.
Conclusion: The most significant aspect of this paper is the documentation of newly recognized relationships between serotonin and dopamine. When transport of serotonin and dopamine are both in the competitive inhibition state, manipulation of the concentrations of one will lead to predictable changes in concentrations of the other. From a functional standpoint, processes regulated and controlled by changes to only serotonin can now be controlled by changes to dopamine, and vice versa, in a predictable manner.

Keywords: catecholamine, monoamine, competitive inhibition state






 

Other articles by Dr Marty Hinz

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Amino acid management of Parkinson’s disease: a case study
Amino acid-responsive Crohn's disease: a case study
Monoamine depletion by reuptake inhibitors
Neurotransmitter testing of the urine: a comprehensive analysis
Relative nutritional deficiencies associated with centrally acting monoamines
The discrediting of the monoamine hypothesis
The dual-gate lumen model of renal monoamine transport
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”


Readers of this article also read: